TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 299 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $5,000 | -64.3% | 277 | -67.5% | 0.00% | -66.7% |
Q2 2021 | $14,000 | -26.3% | 852 | -19.4% | 0.00% | -25.0% |
Q1 2021 | $19,000 | 0.0% | 1,057 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $19,000 | -24.0% | 1,057 | -23.5% | 0.00% | -42.9% |
Q3 2020 | $25,000 | -13.8% | 1,381 | -15.2% | 0.01% | -30.0% |
Q2 2020 | $29,000 | +11.5% | 1,628 | -3.7% | 0.01% | -9.1% |
Q1 2020 | $26,000 | -46.9% | 1,691 | -32.5% | 0.01% | -8.3% |
Q4 2019 | $49,000 | +1125.0% | 2,506 | +948.5% | 0.01% | +500.0% |
Q3 2019 | $4,000 | -91.3% | 239 | -90.8% | 0.00% | -90.0% |
Q2 2019 | $46,000 | – | 2,611 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |